Showing results (161-170 of 645) with videos related to

Sort By:
Pageof 65
Circulation|August 10, 2012
Missed opportunities: despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remainsSumeet Subherwal, Manesh R Patel, Lars Kober, et al.
Cardiology in Review|April 14, 2004
An intracardiac mass in a young man with congenitally acquired HIVManesh R Patel, Louise E J Thomson, Trip J Meine, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|December 16, 2005
The case of the disappearing myxomaJohn F Heitner, Igor Klem, Karen Alexander, et al.
American Journal of Preventive Cardiology|April 15, 2025
Generalizability of VICTORION-1 PREVENT enrollment criteria to the United States populationRahul Aggarwal, Deepak L Bhatt, Marc P Bonaca, et al.
Cardiovascular Diagnosis and Therapy|November 23, 2020
The role of intracoronary imaging in translational researchNicholas J Montarello, Adam J Nelson, Johan Verjans, et al.
International Journal of Cardiology|October 3, 2021
Instantaneous wave-free ratio compared with fractional flow reserve in PCI: A cost-minimization analysisKarolina Berntorp, Josefine Persson, Sasha M Koul, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|January 29, 2019
PLX-PAD Cell Treatment of Critical Limb Ischaemia: Rationale and Design of the PACE TrialLars Norgren, Norbert Weiss, Sigrid Nikol, et al.
American Heart Journal|January 13, 2024
Identifying the highest risk vascular patients: Insights from the XATOA registrySonia S Anand, Victor Aboyans, Jackie Bosch, et al.
American Heart Journal|November 2, 2013
Prognostic implications of left ventricular end-diastolic pressure during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Findings from the Assessment of Pexelizumab in Acute Myocardial Infarction studyAkshay Bagai, Paul W Armstrong, Amanda Stebbins, et al.
American Heart Journal|May 22, 2012
Variations in practice and outcomes in patients undergoing primary percutaneous coronary intervention in the United States and Canada: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI) trialRajendra H Mehta, Padma Kaul, Renato D Lopes, et al.
Pageof 65